Answers are grounded in this paper and cite their sources.
Dupuytren's disease is a common, costly and recurrent health issue. This review compares Clostridium histolyticum collagenase with current operative treatments. Collagenase management is an effective non-surgical alternative associated with lower risks of serious adverse events, but higher incidence of non-serious adverse events.
No takes yet. Share an insight, caveat, or question.
Azzopardi et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: